Cargando…

How challenging is to manage agitated patients?

Detalles Bibliográficos
Autores principales:	Cavalcante, Daniel A., Gadelha, Ary, Noto, Cristiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804306/ https://www.ncbi.nlm.nih.gov/pubmed/31365715 http://dx.doi.org/10.1590/1516-4446-2019-4105

Ejemplares similares

T121. BLUNTED AFFECT EARLY PROGRESSION IN DRUG-NAïVE FIRST EPISODE SCHIZOPHRENIA PATIENTS: 10-WEEK FOLLOW UP
por: Kagan, Simão, et al.
Publicado: (2020)

T97. CANNABIS USE IMPACTS SYMPTOM PRESENTATION IN ANTIPSYCHOTIC NAIVE PATIENTS IN FIRST EPISODE OF PSYCHOSIS (FEP)
por: Coutinho, Luccas, et al.
Publicado: (2018)

T119. NO DIFFERENCE BETWEEN VOLITIVE AND EXPRESSIVE NEGATIVE SYMPTOMS FOR EARLY TREATMENT RESPONSE IN FIRST EPISODE OF PSYCHOSIS ANTIPSYCHOTIC NAïVE PATIENTS
por: Haguiara, Bernardo, et al.
Publicado: (2020)

O8.2. DURATION OF UNTREATED PSYCHOSIS (DUP) IS ASSOCIATED WITH WORSE RESPONSE TO TREATMENT IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOSIS
por: Cavalcante, Daniel, et al.
Publicado: (2018)

M200. CLOZAPINE-INDUCED HEPATOTOXICITY: TWO CASE REPORTS
por: Dias, Cintia, et al.
Publicado: (2020)

S128. CORRELATION OF DURATION OF UNTREATED PSYCHOSIS WITH TREATMENT RESPONSE ON THE SYMPTOM DIMENSIONS OF SCHIZOPHRENIA
por: Elias, Beatriz Yukie, et al.
Publicado: (2018)

COVID-19 pandemic and distinct patterns of psychotic outbreaks
por: Costardi, Carlos Gustavo, et al.
Publicado: (2021)

COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey
por: Costardi, Carlos Gustavo, et al.
Publicado: (2022)

The Late Agitation Arising from an Advertisement
Publicado: (1878)

T100. NICOTINE USE IMPACTS NEGATIVE SYMPTOMS SEVERITY IN SCHIZOPHRENIA
por: Oliveira, Hianna, et al.
Publicado: (2018)

Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
por: Millán-Calenti, José Carlos, et al.
Publicado: (2016)

Anti-Tuberculosis Agitation
Publicado: (1907)

Mechanism of emergence agitation induced by sevoflurane anesthesia
por: Kim, Jae Hwan
Publicado: (2011)

Emergence agitation/delirium: we still don't know
por: Kwak, Kyung Hwa
Publicado: (2010)

Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020)

Changes in practice for mechanically ventilated patients: effect of the pain, agitation, and delirium guidelines
por: Huh, Jin Won
Publicado: (2022)

Issues in the Management of Acute Agitation: How Much Current Guidelines Consider Safety?
por: Pacciardi, Bruno, et al.
Publicado: (2013)

Protocol for the management of psychiatric patients with psychomotor agitation
por: Vieta, Eduard, et al.
Publicado: (2017)

T117. INVESTIGATION OF FORMAL THOUGHT DISORDER AND RESPONSE TO TREATMENT IN SCHIZOPHRENIA
por: Loures Malinowski, Fernando Rocha, et al.
Publicado: (2018)

Agitated Psychiatric Patient
por: Pabst, Brooke M, et al.
Publicado: (2020)

On Agitation
Publicado: (1920)

Management of Agitation in Behaviours That Challenge in Dementia Care: Multidisciplinary Perspectives on Non-Pharmacological Strategies
por: James, Ian Andrew, et al.
Publicado: (2023)

Challenges of Agitation in Dementia: A Plea for Early Discussion
por: Richler, Leah G., et al.
Publicado: (2023)

Management of Agitation During the COVID-19 Pandemic
por: Wong, Ambrose H., et al.
Publicado: (2020)

Schizophrenia and COVID-19: risks and recommendations
por: Fonseca, Lais, et al.
Publicado: (2020)

1st International Experts’ Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation
por: Martínez-Raga, José, et al.
Publicado: (2018)

S129. DOES TREATMENT RESISTANT SCHIZOPHRENIA PRESENT A CHARACTERISTIC SYMPTOMATIC SIGNATURE?
por: Bertolucci, Bruno, et al.
Publicado: (2018)

Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
por: Koga, Gabriela, et al.
Publicado: (2022)

The influence of pain, agitation, and their management on the immature brain
por: McPherson, Christopher, et al.
Publicado: (2020)

Assessment and Management of Agitation in Consultation-Liaison Psychiatry
por: Raveesh, Bevinahalli Nanjegowda, et al.
Publicado: (2022)

Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best Practices in the Evaluation and Treatment of Agitation)
por: Roppolo, Lynn P., et al.
Publicado: (2020)

The Fate of the Agitator
Publicado: (1918)

Clozapine prescription trends in Brazil in the last decade
por: Massuda, Raffael, et al.
Publicado: (2022)

Ultrasonography performed by nephrologists: reality and challenges
por: Araújo, Nordeval Cavalcante
Publicado: (2021)

Microbial Ecology in Anaerobic Digestion at Agitated and Non-Agitated Conditions
por: Tian, Zhuoli, et al.
Publicado: (2014)

A reflection on the use of Antidepressants to manage agitation in dementia
por: Basto, M.D.R.D.R.F.D., et al.
Publicado: (2022)

Correction to “Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best Practices in the Evaluation and Treatment of Agitation)”
Publicado: (2023)

Amlodipine and the Successful Management of Post-Electroconvulsive Therapy Agitation
por: Shahriari, Ali, et al.
Publicado: (2016)

Management of Agitation in Huntington’s Disease: A Review of the Literature
por: Rossi, Garrett, et al.
Publicado: (2020)

Managing acute agitation and aggression in the world of drug shortages
por: Miller, Jennifer
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qvdu0shm6l07321is98jkt7sge